RSS-Feed abonnieren
DOI: 10.1055/s-0041-108911
Neurologische Erkrankungen und Schwangerschaft – eine Übersicht
Neurological Disorders and PregnancyPublikationsverlauf
Publikationsdatum:
08. März 2016 (online)
![](https://www.thieme-connect.de/media/fdn/201602/lookinside/thumbnails/fdnp-042_10-1055-s-0041-108911-1.jpg)
Zusammenfassung
Neurologische Erkrankungen, die durch eine Schwangerschaft ausgelöst werden, sind das posteriore reversible Enzephalopathiesyndrom (PRES), das Fruchtwasser-Embolie-Syndrom, das Sheehan-Syndrom und die Post-partum-Angiopathie – das reversible zerebrale Vasokonstriktionssyndrom (RCVS). Zu den diagnostischen Kriterien der Präeklampsie zählen Blutdruckerhöhung und Proteinurie; bei epileptischen Anfällen liegt eine Eklampsie vor. Hämolyse, erhöhte Leberenzyme und niedrige Thrombozytenzahlen (low platelets) sind Leitsymptome des HELLP-Syndroms. Sehstörungen bis zur kortikalen Blindheit charakterisieren das posteriore reversible Enzephalopathiesyndrom (PRES). Das Sheehan-Syndrom zeigt sich als Hypopituitarismus post partum und kommt durch einen Apoplex der Hypophyse bei peripartalen Blutungen mit längerfristigem Blutdruckabfall zustande. Zu den neurologischen Krankheiten, die während einer Schwangerschaft gehäuft auftreten, zählen Schlaganfälle, die Sinusvenenthrombose, das Restless-Legs-Syndrom und Nervenkompressionssyndrome. Chronische neurologische Erkrankungen müssen während einer Schwangerschaft interdisziplinär überwacht und betreut werden. Die Einnahme von Antikonvulsiva während der Schwangerschaft verdoppelt das Risiko von Geburtsdefekten; das höchste Risiko besteht für Valproinsäure. Das geringste Fehlbildungsrisiko weisen Lamotrigin und Levetiracetam auf. Bei MS-Patientinnen sind nach Registerdaten Glatirameracetat und Interferone als Intervalltherapeutika während der Gravidität relativ sicher. Alle anderen Substanzen sollten abgesetzt werden.
Abstract
Neurological disorders caused by pregnancy and puerperium include the posterior reversible encephalopathy syndrome, the amniotic fluid embolism syndrome (AFES), the postpartum angiopathy due to reversible vasoconstriction syndrome, and the Sheehan syndrome. Hypertension and proteinuria are the hallmarks of preeclampsia, seizures define eclampsia. Hemolysis, elevated liver enzymes and low platelets constitute the HELLP syndrome. Vision disturbances including cortical blindness occur in the posterior reversible encephalopathy syndrome (PRES). The Sheehan syndrome presents with panhypopituitarism post partum due to apoplexia of the pituitary gland in severe peripartal blood loss leading to longstanding hypotension. Some neurological disorders occur during pregnancy and puerperium with an increased frequency. These include stroke, sinus thrombosis, the restless legs syndrome and peripheral nerve syndromes, especially the carpal tunnel syndrome. Chronic neurologic diseases need an interdisciplinary approach during pregnancy. Some anticonvulsants double the risk of birth defects. The highest risk exists for valproic acid, the lowest for lamotrigine and levetiracetam. For MS interval treatment, glatiramer acetate and interferones seem to be safe during pregnancy. All other drugs should be avoided.
-
Literatur
- 1 Cnossen JS, Vollebregt KC, de Vrieze N et al. Accuracy of mean arterialpressure and blood pressure measurements in predicting preeclampsia:systematic review and meta-analysis. BMJ 2008; 336: 1117-1120
- 2 Brewer J, Owens MY, Wallace K et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013; 208: 468
- 3 Fletcher JJ, Kramer AH, Bleck TP et al. Overlapping features of eclampsia and postpartum angiopathy. Neurocrit care 2009; 11: 199-209
- 4 Crovetto F, Somigliana E, Peguero A et al. Stroke during pregnancy and preeclampsia. Current opinion in obstetrics & gynecology 2013; 25: 425-432
- 5 Sawle GV, Ramsay MM. The neurology of pregnancy. J Neurol Neurosurg and Psychiatry 1998; 64: 711-725
- 6 [Anonym]. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-1463
- 7 Fugate JE, Ameriso SF, Ortiz G et al. Variable presentations of postpartum angiopathy. Stroke 2012; 43: 670-676
- 8 Call GK, Fleming MC, Sealfon S et al. Reversible cerebral segmental vasoconstriction. Stroke 1988; 19: 1159-1170
- 9 Raps EC, Galetta SL, Broderick M et al. Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol 1993; 33: 222-225
- 10 Fugate JE et al. Fulminant postpartum cerebral vasoconstriction syndrome. Arch Neurol 2012; 6: 1111-1117
- 11 Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care 2005; 3: 91-97
- 12 Krämer M, Berlit P. Reversibles zerebrales Vasokonstriktionssyndrom vs. zerebrale Vaskulitis. Nervenarzt 2012; 82: 500-505
- 13 Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency. Ther Adv Neurol Disord 2010; 3: 161-171
- 14 Kramer MS, Rouleau J, Baskett TF et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 2006; 368: 1444-1448
- 15 Sipes SL, Malee MP. Endocrine disorders in pregnancy. Obstet Gynecol Clin North Am 1992; 19: 655-677
- 16 Harbeck B, Schutt M, Sayk F. Endocrine emergencies during pregnancy. Med Klin Intensivmed Notfallmed 2012; 107: 110-117
- 17 Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31: 1274-1282
- 18 Lanska DJ, Kryscio RJ. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 1998; 51: 1622-1628
- 19 Canhao P, Ferro JM, Lindgren AG et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36: 1720-1725
- 20 Einhäupl K, Stam J, Bousser MG et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol 2010; 17: 1229-1235
- 21 Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245
- 22 Seshadri S, Beiser A, Kelly-Hayes M et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345-350
- 23 Lamy C, Sharshar T, Mas JL. Cerebrovascular diseases in pregnancy and puerperium. Revue neurologique 1996; 152: 422-440
- 24 James AH, Bushnell CD, Jamison MG et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509-516
- 25 Kittner SJ, Stern BJ, Feeser BR et al. Pregnancy and the risk of stroke. N Eng J Med 1996; 335: 768-774
- 26 Berlit P, Schönenberger S. Schwangerschaft und Schlaganfall. Akt Neurol 2014; 41: 443-446
- 27 Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995; 26: 930-936
- 28 Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 2000; 31: 2948-2951
- 29 Krämer M, Berlit P. Die Moyamoya-Erkrankung – Eine seltene Vasopathie bei europäischen Patienten. Fortschritte Neurol Psychiatr 2010; 78: 542-553
- 30 Leonhardt G, Gaul C, Nietsch HH et al. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006; 21: 271-276
- 31 Broderick JP. Should intravenous thrombolysis be considered the first option in pregnant women?. Stroke 2013; 44: 866-867
- 32 Saver JL, Goyal M, Bonafe A et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med DOI: 10.1056/NEJMoa1415061.
- 33 Goyal M, Demchuk AM, Menon BK et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019-1030
- 34 Campbell BC, Mitchell PJ, Kleinig TJ et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009-1018
- 35 Berkhemer OA, Fransen PS, Beumer D et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
- 36 Bateman BT, Schumacher HC, Bushnell CD et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 2006; 67: 424-429
- 37 Padua L, Aprile I, Caliandro P et al. Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy. Clin Neurophysiol 2001; 112: 1946
- 38 Cohen Y, Lavie O, Granovsky-Grisaru S et al. Bell palsy complicating pregnancy: a review. Obstet Gynecol Surv 2000; 55: 184
- 39 Wong CA, Scavone BM, Dugan S et al. Incidence of postpartum lumbosacral spine and lower extremity nerve injuries. Obstet Gynecol 2003; 101: 279
- 40 Feasby TE, Burton SR, Hahn AF. Obstetrical lumbosacral plexus injury. Muscle Nerve 1992; 15: 937
- 41 Neyal A et al. A prospective study of Willis-Ekbom disease/restless legs syndrome during and after pregnancy. Sleep Med 2015; 16: 1036-1040
- 42 Cardoso F. Chorea gravidarum. Arch Neurol 2002; 59: 868
- 43 Berlit P. Memorix Neurologie. 2016 (im Druck)
- 44 MacGregor EA. Headache in pregnancy. Neurol Clin 2012; 30: 835
- 45 Sances G, Granella F, Nappi RE et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23: 197
- 46 Goldszmidt E, Kern R, Chaput A et al. The incidence and etiology of postpartum headaches: a prospective cohort study. Can J Anaesth 2005; 52: 971
- 47 Kraayvanger L, Berlit P. Postpartale sekundäre Sinusvenenthrombose mit axialer transtentorieller und tonsillärer Herniation als seltene Komplikation eines Liquorunterdrucksyndroms nach spinaler Anästhesie. Fortschr Neurol Psychiatr 2014; 82: 1-3